CompletedNCT00001721
Study of Smith-Lemli-Opitz Syndrome
Studying 46,XY difference of sex development due to a cholesterol synthesis defect
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Principal Investigator
- Forbes D Porter, M.D.Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Intervention
- Cholesterol Suspension(drug)
- Enrollment
- 130 enrolled
- Eligibility
- All sexes
- Timeline
- 1998
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00001721 on ClinicalTrials.gov